… with atrial fibrillation contributing 32,888 person-years of follow-up on warfarin, obtaining
data from clinical databases and validating hemorrhage events using medical record review. …

… or paroxysmal AF, sustained atrial flutter, intracardiac thrombus, prosthetic cardiac valve, …
will compare dabigatran etexilate and rivaroxaban, respectively, to aspirin in ESUS patients. …

… for stroke prevention in atrial fibrillation, treatment of venous … stages of development are
dabigatran etexilate, a direct … the treatment of VTE and prevention of stroke in patients with …

… Other independent predictors of cost included stroke severity, heparin treatment, atrial
fibrillation, male sex, ischemic cardiac disease, and premorbid functional status. …

… Rate Control Therapy Evaluation in Permanent Atrial Fibrillation 251 RCT … Evaluation of
dabigatran etexilate Compared to warfarin in pulmonaRy vein 253 ablation: assessment of …

… : This review discusses the current state of coumarin pharmacogenetics, the evidence from
recent randomized controlled trials and economic evaluations … of coumarin treatment. Current …

… In this review article, we will focus on stroke prevention in AF, … review article, we will focus
on stroke prevention in AF, and the clinical impact of CKD and its implications for management. …

… To assess the association between LAVI and detection of atrial fibrillation in patients with
ESUS, we performed a multivariate regression analysis adjusting for age. Our analysis was …

… Atrial fibrillation (AF) is the most frequent arrhythmia encountered in clinical practice and
is … In this article, we review the available data regarding the prognostic role of RDW in AF …

… We categorized PES as follows: atrial cardiopathy, atrial fibrillation diagnosed during follow‐up,
arterial disease, left ventricular disease, cardiac valvular disease, patent foramen ovale, …